Overview of Ocular Side Effects of Selinexor.

Author: AhnertJordi Rodon, Al-ZubidiNagham, BernstamFunda Meric, FuSiqing, GombosDan S, HongDavid S, KarpDaniel D, NaingAung, Piha-PaulSarina A, SubbiahVivek, TsimberidouApostolia M

Paper Details 
Original Abstract of the Article :
BACKGROUND: The aim of this review is to elucidate the type and frequency of ocular adverse events associated with selinexor with a goal to quantify the occurrence of these events in our investigator-initiated trial. METHODS: We retrospectively reviewed medical records of 174 patients treated with ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265354/

データ提供:米国国立医学図書館(NLM)

Selinexor: A Camel's Journey Through the Desert of Ocular Side Effects

Selinexor, a promising new drug for treating cancer, has shown potential in treating a variety of malignancies. This study explored the ocular side effects associated with selinexor treatment.

Navigating the Side Effects: A Camel's Guide to Selinexor Treatment

The researchers reviewed medical records of 174 patients who received selinexor treatment. They found that the most common ocular side effects were blurred vision and dry eye syndrome.

Selinexor: A Camel's Perspective on Cancer Treatment and Vision

This study highlights the importance of monitoring for ocular side effects in patients receiving selinexor treatment. While these side effects are generally mild, they can impact vision and quality of life.

Dr. Camel's Conclusion

The researchers found that ocular side effects associated with selinexor treatment were generally mild. The most common side effects were blurred vision and dry eye syndrome. While these side effects are manageable, they underscore the importance of ongoing monitoring for any potential vision changes in patients receiving selinexor.
Date :
  1. Date Completed 2021-07-12
  2. Date Revised 2022-05-31
Further Info :

Pubmed ID

33728727

DOI: Digital Object Identifier

PMC8265354

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.